ArticleResearch square2023
Structure-Informed Protein Language Models are Robust Predictors for Variant Effects.
Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
2 authors.
Funding
Abstract
Predicting protein variant effects through machine learning is often challenged by the scarcity of experimentally measured effect labels. Recently, protein language models (pLMs) emerge as zero-shot predictors without the need of effect labels, by modeling the evolutionary distribution of functional protein sequences. However, biological contexts important to variant effects are implicitly modeled and effectively marginalized. By assessing the sequence awareness and the structure awareness of pLMs, we find that their improvements often correlate with better variant effect prediction but their tradeoff can present a barrier as observed in over-finetuning to specific family sequences. We introduce a framework of structure-informed pLMs (SI-pLMs) to inject protein structural contexts purposely and controllably, by extending masked sequence denoising in conventional pLMs to cross-modality denoising. Our SI-pLMs are applicable to revising any sequence-only pLMs through model architecture and training objectives. They do not require structure data as model inputs for variant effect prediction and only use structures as context provider and model regularizer during training. Numerical results over deep mutagenesis scanning benchmarks show that our SI-pLMs, despite relatively compact sizes, are robustly top performers against competing methods including other pLMs, regardless of the target protein family's evolutionary information content or the tendency to overfitting / over-finetuning. Learned distributions in structural contexts could enhance sequence distributions in predicting variant effects. Ablation studies reveal major contributing factors and analyses of sequence embeddings provide further insights. The data and scripts are available at https://github.com/Stephen2526/Structure-informed_PLM.git.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.